Middletown, Delaware, USA

Formulation Development and Manufacturing

Coming soon. The new 190-acre site will offer formulation development and manufacturing from preclinical to commercial manufacturing.

Phase I of the site is designed for the development and manufacturing of oral and parenteral drug products, including packaging, labeling, and distribution.

Site Virtual Tour

Site Related News

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to an...

WuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus

WuXi STA bringing about 500 jobs to Middletown WILMINGTON, Del. (June 28, 2021) — WuXi STA and Delaware Prosperity Partnership today announced th...

WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware

MIDDLETOWN, Delaware, August 16, 2022 – WuXi STA, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), is pleased to an...

WuXi STA Chooses Middletown Delaware for New Pharmaceutical Manufacturing Campus

WuXi STA bringing about 500 jobs to Middletown WILMINGTON, Del. (June 28, 2021) — WuXi STA and Delaware Prosperity Partnership today announced th...

Oral

Parenteral

Oral

Parenteral

Clinical Supply Service

Middletown, Delaware, USA